Analysed DAIICHI SANKYO CO LTD (DSKYF:OTCMKTS) News Sources
Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression on or After Platinum-Based Chemotherapy
13-04-2026
yahoo.com
ATLATL Announces Agreement with Daiichi Sankyo to Deepen APAC Biotech Innovation
08-04-2026
yahoo.com
Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib from Daiichi Sankyo
01-04-2026
yahoo.com
Guardant Health’s InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan
30-03-2026
yahoo.com
Cathie Wood Chooses Medical AI Over Mark Zuckerberg: Ark Loads Up On TEM Stock, Dumps Meta Shares
28-03-2026
yahoo.com
What is the current price of DAIICHI SANKYO CO LTD (DSKYF:OTCMKTS)?
The current price of DAIICHI SANKYO CO LTD (DSKYF:OTCMKTS) is $17.41.
DAIICHI SANKYO CO LTD (DSKYF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of DAIICHI SANKYO CO LTD (DSKYF:OTCMKTS) since the previous trading day is $-0.37.
DAIICHI SANKYO CO LTD (DSKYF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of DAIICHI SANKYO CO LTD (DSKYF:OTCMKTS) since the previous trading day is -2.081%.
What is the most recent average sentiment score for DAIICHI SANKYO CO LTD (DSKYF:OTCMKTS)?
The most recent average sentiment score for DAIICHI SANKYO CO LTD (DSKYF:OTCMKTS) is 80 out of 100.
What is the most recent average sentiment for DAIICHI SANKYO CO LTD (DSKYF:OTCMKTS)?
The most recent sentiment for DAIICHI SANKYO CO LTD (DSKYF:OTCMKTS) is .
SEC-8K** Filing Available For DAIICHI SANKYO CO LTD (DSKYF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.